4 min read

Daily Filing Digest — Saturday, 3 Oct 2026

3 Oct 2026: seven more banks report Q2, Vedanta Oil & Gas loses Cambay to ONGC, JLR wholesales recover, DMart revenue up 18%.

A Saturday full of Q2 numbers. Seven more banks filed their September figures, taking our tracker to 22; Jammu & Kashmir Bank's loans grew 7.4 points faster than its deposits. Vedanta Oil & Gas's output fell 19% after ONGC took over its Cambay block. JLR's wholesales recovered from last year's cyber incident, but retail sales fell, led by China. DMart's quarterly revenue rose 18%.

The one to read first

Seven more banks reported Q2: Bank of Baroda (deposits +16.75%, advances +18.27%), Bank of India (+21.60%, +20.43%), IDBI Bank (+17%, net advances +18%), Jammu & Kashmir Bank (+16.29%, +23.72%; CASA ratio down 388 bps), AU Small Finance Bank (+28.6%, gross advances +27.9%), Ujjivan SFB (+29.2%, loan book +32.1%) and Bandhan Bank (+9.2%, +13.1%; CASA ratio 26.71% from 29.40% in June).

Full read: Q2 Bank Scoreboard: 22 Banks Ranked From Their Filings

Lenders: Q2 updates

  • Bajaj Finance AUM grew 26.5% to about ₹5,84,750 crore; new loans booked rose 11% to 13.45 million and the customer franchise reached 128.85 million. (Two days after its board approved a ₹17,500 crore raise: our note.)
  • Bajaj Housing Finance AUM grew 25% to about ₹1,58,190 crore; Q2 disbursements were about ₹19,930 crore against ₹15,914 crore.
  • L&T Finance estimates retail disbursements of ~₹24,000 crore (+27%) and a retail book of ~₹1,34,500 crore (+29%).
  • Kissht (OnEMI) AUM grew 68.4% to about ₹9,317 crore.
  • SRG Housing Finance made a voluntary disclosure that it has no overdues to lenders and adequate liquidity, and that management is "actively evaluating the infusion of fresh capital". The filing does not say what prompted it.

Operations

Tax, courts and regulators

  • RattanIndia Power: an arbitral tribunal awarded BHEL a net ₹170.78 crore plus interest on part of it, in the Amravati Phase-II dispute.
  • Skipper's GST notice was rectified down to ₹40.96 crore from ₹227.53 crore; the company contests it.
  • Nectar Lifesciences: the Punjab & Haryana High Court sent a GST matter back to the appellate authority; the company's potential exposure is ₹89.32 crore plus a separate ₹6.24 crore demand.
  • Sai Parenterals' monitoring agency, India Ratings, reported deviations of up to ₹238.74 million in the use of IPO proceeds for the June quarter, including funds moved out of the monitoring account and not used the same day.
  • Sadhav Shipping (SME): JNPA withdrew its five-year debarment after the company challenged it in the Bombay High Court.
  • Aurobindo Pharma got USFDA final approval for perampanel tablets (US market ~US$67 million).

Deals and capital

Orders

Stakes, people and credit


Educational research, not investment advice. Every figure above is drawn from the named company's own filing dated 3 October 2026 and checked against the source; amounts are rounded from the filed figures, and derived figures are our arithmetic. No buy/sell recommendations, no price targets, no share prices. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.